PI3K/AKT PATHWAY IS INVOLVED IN MDS PATHOGENESIS AND MAY CONSTITUTE A POTENTIAL THERAPEUTIC TARGET

被引:0
|
作者
Rezende, D. C. [1 ]
Pacheco, L. Z. [1 ]
Pelloso, L. A. F. [1 ]
Chauffaille, M. L. L. F. [1 ]
Yamamoto, Y. [1 ]
Silva, M. [2 ]
Kerbauy, D. B. [1 ]
机构
[1] UNIFESP EPM, Sao Paulo, Brazil
[2] HSPE FMO, Serv Hematol, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
174
引用
收藏
页码:S82 / S82
页数:1
相关论文
共 50 条
  • [31] Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress
    Duan, Yi
    Haybaeck, Johannes
    Yang, Zhihui
    CANCERS, 2020, 12 (10) : 1 - 21
  • [32] Therapeutic Potential of PI3K/Akt/mTOR Signalling Pathway: Effective Combination Therapy for Cancer
    Kawade, V. S.
    Satpute, P. S.
    Dhulap, S. A.
    Gurjar, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 702 - 708
  • [33] Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress
    Bahrami, Afsane
    Khazaei, Majid
    Hasanzadeh, Malihe
    ShahidSales, Soodabeh
    Joudi Mashhad, Mona
    Farazestanian, Marjaneh
    Sadeghnia, Hamid Reza
    Rezayi, Majid
    Maftouh, Mina
    Hassanian, Seyed Mahdi
    Avan, Amir
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (03) : 2460 - 2469
  • [34] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198
  • [35] PI3K/Akt/mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
    Narayanankutty, Arunaksharan
    CURRENT DRUG TARGETS, 2019, 20 (12) : 1217 - 1226
  • [36] Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
    Akutagawa, J.
    Huang, T. Q.
    Epstein, I.
    Chang, T.
    Quirindongo-Crespo, M.
    Cottonham, C. L.
    Dail, M.
    Slusher, B. S.
    Friedman, L. S.
    Sampath, D.
    Braun, B. S.
    LEUKEMIA, 2016, 30 (06) : 1335 - 1343
  • [37] Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
    J Akutagawa
    T Q Huang
    I Epstein
    T Chang
    M Quirindongo-Crespo
    C L Cottonham
    M Dail
    B S Slusher
    L S Friedman
    D Sampath
    B S Braun
    Leukemia, 2016, 30 : 1335 - 1343
  • [38] PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
    Alberobello, Anna Teresa
    Wang, Yisong
    Beerkens, Frans Joseph
    Conforti, Fabio
    McCutcheon, Justine N.
    Rao, Guanhua
    Raffeld, Mark
    Liu, Jing
    Rahhal, Raneen
    Zhang, Yu-Wen
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : 1345 - 1356
  • [39] Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury
    Kitagishi Y.
    Matsuda S.
    Alzheimer's Research & Therapy, 5 (5)
  • [40] Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury
    Kitagishi, Yasuko
    Matsuda, Satoru
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (05):